Recro Pharma, Inc. (REPH) Stock Analysis
DELISTED 2022
What happened to Recro Pharma, Inc. (REPH) stock?
Recro Pharma, Inc. (REPH) no longer trades on public markets. It was delisted in March 2022. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2022
- Last recorded price (historical):
- $2.09 (last quote on record before the March 2022 delisting; historical, not a current quote)
Market cap $177M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
This page is the archived listing record for Recro Pharma, Inc. (REPH), kept for historical reference only.
Recro Pharma, Inc. (REPH) Healthcare & Pipeline Overview
More about this archive record
Can I still buy REPH shares?
No. REPH stopped trading on public markets in March 2022, so the shares are not available through a broker. Anything you see quoted for REPH elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before REPH stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Recro Pharma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.